![Servier - Moved by you..]({"type":"image" , "src" : "/sda/112354/JournalAd-Servier-5s.gif"})
https://orcid.org/0000-0002-7516-9113
Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Di Zhu, Chi Wang, You Zhou, Hebin Che, Ruiqing Wang, Liting Cheng, Chongyou Rao, Qin Zhong, Zongren Li, Yongjie Duan & Kunlun He. (2024) The Associations of Two Novel Inflammation Biomarkers, SIRI and SII, with Mortality Risk in Patients with Chronic Heart Failure. Journal of Inflammation Research 17, pages 1255-1264.
Read now
Read now
Sanling Shi, Shuting Kong, Weicheng Ni, Yucheng Lu, Junfeng Li, Yuheng Huang, Jinxin Chen, Ken Lin, Yuanmiao Li, Jiayu Ke & Hao Zhou. (2023) Association of the Systemic Immune-Inflammation Index with Outcomes in Acute Coronary Syndrome Patients with Chronic Kidney Disease. Journal of Inflammation Research 16, pages 1343-1356.
Read now
Read now
Adil Bayramoğlu & Şıho Hidayet. (2023) Association between pan-immune-inflammation value and no-reflow in patients with ST elevation myocardial infarction undergoing percutaneous coronary intervention. Scandinavian Journal of Clinical and Laboratory Investigation 83:6, pages 384-389.
Read now
Read now
Gökhan Demirci, Ahmet A Şahin, Tuğba Aktemur, Ali R Demir, İlyas Çetin, Enes Arslan, Ayan Işık, İsmail Gürbak & Mehmet Ertürk. (2023) Relationship Between Systemic Immune-Inflammation Index and No-Reflow in Percutaneous Coronary Intervention for Saphenous Grafts. Biomarkers in Medicine 17:8, pages 427-435.
Read now
Read now
Elmas Kaplan, Firdevs A Ekızler, Halenur Saribaş, Bahar T Tak, Serkan Cay, Ahmet Korkmaz, Ozcan Ozeke, Fırat Ozcan, Serkan Topaloglu & Dursun Aras. (2023) Effectiveness of the Systemic Immune Inflammation Index to Predict Atrial Fibrillation Recurrence After Cryoablation. Biomarkers in Medicine 17:2, pages 101-109.
Read now
Read now
Görkem Kuş, Göksel Çağırcı, Nermin Bayar, Edip C Özgünoğlu, Ramazan Güven & Şakir Arslan. (2022) Usefulness of the Systemic Immune-Inflammation Index in Predicting Atrial Fibrillation Recurrence After Direct Current Cardioversion. Biomarkers in Medicine 16:11, pages 847-855.
Read now
Read now
Kerim Esenboğa, Alparslan Kurtul, Yakup Yunus Yamantürk, İrem Müge Akbulut & Durmuş Eralp Tutar. (2022) Comparison of systemic immune-inflammation index levels in patients with isolated coronary artery ectasia versus patients with obstructive coronary artery disease and normal coronary angiogram. Scandinavian Journal of Clinical and Laboratory Investigation 82:2, pages 132-137.
Read now
Read now
Articles from other publishers (35)
Lei Wang & Jin-Jiao Shan. (2023) Systemic Inflammation Index as a Novel Biomarker of No-Reflow Phenomenon in Patients With Acute Myocardial Infarction. Angiology 75:5, pages 496-497.
Crossref
Crossref
Luke P. Dawson, Muhammad Rashid, Diem T. Dinh, Angela Brennan, Jason E. Bloom, Sinjini BiswasJeffrey Lefkovits, James A. ShawWilliam Chan, David J. ClarkErnesto Oqueli, Chin HiewMelanie FreemanAndrew J. Taylor, Christopher M. Reid, Andrew E. AjaniDavid M. Kaye, Mamas A. Mamas & Dion Stub. (2024) No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score. Circulation: Cardiovascular Interventions 17:4.
Crossref
Crossref
Süleyman Akkaya & Umit Cakmak. (2024) The Association Between Systemic Immune Inflammation Index and Intermediate-Term Mortality in Patients with Acute Coronary Syndromes. Harran Üniversitesi Tıp Fakültesi Dergisi, pages 88-94.
Crossref
Crossref
Ailin Liu, Na Sun, Feiyu Gao, Xiaotong Wang, Hong Zhu & Defeng Pan. (2024) The prognostic value of dynamic changes in SII for the patients with STEMI undergoing PPCI. BMC Cardiovascular Disorders 24:1.
Crossref
Crossref
Sarah R. McLarnon. 2011. Comprehensive Physiology. Comprehensive Physiology
5325
5343
.
Mustafa KAPLANGORAY, Kenan TOPRAK, Cihan AYDIN & Ramazan ASLAN. (2023) Investigation of the relationship between modified Glasgow prognostic score and no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. The European Research Journal 9:5, pages 894-902.
Crossref
Crossref
Gjin Ndrepepa & Adnan Kastrati. (2023) Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy. Journal of Clinical Medicine 12:17, pages 5592.
Crossref
Crossref
Filippo Dossi, Mario Raccis, Guido Parodi, Alberto Ranieri De Caterina, Umberto Paradossi, Augusto Esposito, Andreina D'Agostino, Giuseppe De Luca & Sergio Berti. (2023)
Prognostic role of
CRP
‐independent inflammatory patterns in patients undergoing primary percutaneous interventions
. European Journal of Clinical Investigation 53:8.
Crossref
Crossref
Faysal Şaylık, Tufan Çınar, Remzi Sarıkaya & İbrahim Halil Tanboğa. (2023) Development and Validation of Nomogram Based on the Systemic-Immune Inflammation Response Index for Predicting Contrast-Induced Nephropathy in ST-Elevation Myocardial Infarction Patients. Angiology.
Crossref
Crossref
Anna Yushchuk, Vasyl Pykaliuk & Olha Korzhyk. (2023) Hematocytological, biochemical, and hemostasis parameters' role in predicting the possibility of the various forms of the COVID‐19 course in hospitalized Ukrainian patients: A cross‐sectional study. Health Science Reports 6:7.
Crossref
Crossref
Jia-Hui Liu, Min Zeng, Yue Zhang & De-Gang Mo. (2022) Letter: Predictive Value of Systemic Immune-Inflammatory Index in No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction. Angiology 74:4, pages 395-396.
Crossref
Crossref
Mehmet Bülent Vatan, Ahmet Can Çakmak, Suret Ağaç, Emre Eynel & Hakan Erkan. (2022) The Systemic Immune-Inflammation Index Predicts Impaired Myocardial Perfusion and Short-Term Mortality in ST-Segment Elevation Myocardial Infarction Patients. Angiology 74:4, pages 365-373.
Crossref
Crossref
Ebru Ozturk, Kerim Esenboga, Alparslan Kurtul, Mustafa Kilickap, Ergun Karaagaoglu & Jale Karakaya. (2023) Measurement of Uncertainty in Prediction of No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention Using Systemic Immune Inflammation Index: The Gray Zone Approach. Diagnostics 13:4, pages 709.
Crossref
Crossref
Jiaqi Wang, Feifei Zhang, Man Gao, Yudan Wang, Xuelian Song, Yingxiao Li, Yi Dang & Xiaoyong Qi. (2023) The Systemic Immune Inflammatory Index Predicts No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention in Older Patients with STEMI. Cardiovascular Innovations and Applications 7:1.
Crossref
Crossref
Guoqi Shen, Haiyan He, Zhen Wang, Hang Qiu, Yinghua Zhu, Di Zheng, Yang Duan, Yuan Lu & Wenhua Li. (2022) Predictive value of SII and sd-LDL for contrast-induced acute kidney injury in STEMI patients undergoing percutaneous coronary intervention. Exploration of Medicine, pages 571-582.
Crossref
Crossref
Jin Ma, Wenting Guo, Jiali Xu, Sijie Li, Changhong Ren, Longfei Wu, Chuanjie Wu, Chuanhui Li, Jian Chen, Jiangang Duan, Qingfeng Ma, Haiqing Song, Wenbo Zhao & Xunming Ji. (2022) Association of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with outcomes in stroke patients achieving successful recanalization by endovascular thrombectomy. Frontiers in Neurology 13.
Crossref
Crossref
Derya Tok, Firdevs Aysenur EkizlerBahar Tekin Tak. (2022) The relation between apical thrombus formation and systemic immune-inflammation index in patients with acute anterior myocardial infarction. Medicine 101:50, pages e32215.
Crossref
Crossref
Shijie Liu, Hongcheng Jiang, Menaka Dhuromsingh, Lei Dai, Yue Jiang & Hesong Zeng. (2022) Evaluation of C-reactive protein as predictor of adverse prognosis in acute myocardial infarction after percutaneous coronary intervention: A systematic review and meta-analysis from 18,715 individuals. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Yehong Liu, Ting Ye, Ke Chen, Gangyong Wu, Yang Xia, Xiao Wang & Gangjun Zong. (2022) A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Emre GÖNÜLLÜ, Furkan KUCUK, Zulfu BAYHAN, Ahmet Tarık HARMANTEPE & Recayi CAPOGLU. (2022) Akut Kolesistitte Kolesistektomi veya Kolesistostomi Yapılması Gerekecek Hastaların Ayırt Edilmesinde Biyolojik İndeksler Kullanılabilir mi?. Sakarya Medical Journal.
Crossref
Crossref
Erdoğan Yaşar & Adil Bayramoğlu. (2022) Systemic Immune-Inflammation Index as a Predictor of Microvascular Dysfunction in Patients With Cardiac Syndrome X. Angiology 73:7, pages 615-621.
Crossref
Crossref
Ahmet Goktug Ertem, Yasin Ozen, Baran Yuksekkaya, Mehmet Akif Erdol, Mehmet Erdoğan, Koray Demirtas, Mustafa Karanfil, Ahmet Akdi, Cagri Yayla & Adnan Burak Akcay. (2022) Association of the Novel Inflammatory Marker Systemic Immune-Inflammation index and Contrast-Induced Nephropathy in Patients Undergoing Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis. Angiology 73:5, pages 422-430.
Crossref
Crossref
Ali Bağcı, Fatih Aksoy & Hasan Aydin Baş. (2021) Systemic Immune-Inflammation Index May Predict the Development of Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction. Angiology 73:3, pages 218-224.
Crossref
Crossref
Hao Wang, Xiaochun Qing, Hua Wang & Yunfei Gu. (2022) Association between Platelet to Neutrophil Ratio (PNR) and Clinical Outcomes in STEMI Patients after Successful pPCI: A Secondary Analysis Based on a Cohort Study. Cardiovascular Therapeutics 2022, pages 1-8.
Crossref
Crossref
Recep Öztürk, Duygu İnan & Barış Güngör. (2021) Systemic Immune-Inflammation Index Is a Predictor of Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction. Angiology 73:2, pages 125-131.
Crossref
Crossref
Uğur Özkan, Muhammet Gürdoğan, Cihan Öztürk, Melik Demir, Ömer Feridun Akkuş, Efe Yılmaz & Servet Altay. (2022) Systemic Immune-Inflammation Index: A Novel Predictor of Coronary Thrombus Burden in Patients with Non-ST Acute Coronary Syndrome. Medicina 58:2, pages 143.
Crossref
Crossref
Ozge Ozcan Abacioglu, Arafat Yildirim, Nermin Yildiz Koyunsever & Salih Kilic. (2021) The ATRIA and Modified-ATRIA Scores in Evaluating the Risk of No-Reflow in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention. Angiology 73:1, pages 79-84.
Crossref
Crossref
Yan Yu & Bao-Ping Yang. (2021) Sodium nitroprusside injection immediately before balloon inflation during percutaneous coronary intervention. World Journal of Clinical Cases 9:36, pages 11248-11254.
Crossref
Crossref
Ahmed Mohammed Shumilah, Arwa Mohammed Othman & Anwar Kasim Al-Madhagi. (2021) Accuracy of neutrophil to lymphocyte and monocyte to lymphocyte ratios as new inflammatory markers in acute coronary syndrome. BMC Cardiovascular Disorders 21:1.
Crossref
Crossref
Oktay Şenöz & Ahmet Erseçgin. (2021) Systemic immune‐inflammation index as a tool for predicting the need for a permanent pacemaker in patients with drug‐induced atrioventricular block. Pacing and Clinical Electrophysiology 44:12, pages 1972-1978.
Crossref
Crossref
Saban Kelesoglu, Yucel Yilmaz, Deniz Elcık, Zeki Çetınkaya, Mehmet Tugrul Inanc, Ali Dogan, Abdurrahman Oguzhan & Nihat Kalay. (2021) Systemic Immune Inflammation Index: A Novel Predictor of Contrast-Induced Nephropathy in Patients With Non-ST Segment Elevation Myocardial Infarction. Angiology 72:9, pages 889-895.
Crossref
Crossref
Ahmet Nalbant, Taner Demirci, Tezcan Kaya, Ayhan Aydın, Mustafa Altındiş & Ertuğrul Güçlü. (2021) Can prognostic nutritional index and systemic immune‐inflammatory index predict disease severity in COVID‐19?. International Journal of Clinical Practice 75:10.
Crossref
Crossref
Ting-Ting Liu, Rui Li, Chen Huo, Jian-Ping Li, Jie Yao, Xiu-li Ji & Yi-Qing Qu. (2021) Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Yinhao Huang, Dazhou Lei, Ziwei Chen & Biao Xu. (2021) Factors associated with microvascular occlusion in patients with ST elevation myocardial infarction after primary percutaneous coronary intervention. Journal of International Medical Research 49:6, pages 030006052110244.
Crossref
Crossref
Oktay ŞENÖZ, Sadık Volkan EMREN, Ahmet ERSEÇGİN, Zeynep YAPAN EMREN & İlker GÜL. (2021) Platelet‐Lymphocyte ratio is a predictor for the development of no‐reflow phenomenon in patients with ST‐segment elevation myocardial infarction after thrombus aspiration. Journal of Clinical Laboratory Analysis 35:6.
Crossref
Crossref
![A worldwide pioneer in biotechnology.]({"type":"image" , "src" : "/sda/112403/JournalAd-Amgen-MPU.png"})
![A bold vision to stop cardiovascular disease from being a leading cause of death.]({"type":"image" , "src" : "/sda/112402/JournalAd-amarin.jpg"})